Fusion Pharmaceuticals Inc. (FUSN)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Avidity Partners Management

David Witzke And Michael Gregory

5,781,850 $15,032,810 +2% 0.6%
2.
OrbiMed Advisors

Samuel Isaly

3,122,770 $8,119,202 0.17%
3. 2,947,809 $7,664,303 2.67%
4.
Deerfield Management

James E. Flynn

2,823,000 $7,339,800 0.16%
5.
Perceptive Advisors

Joseph Edelman

2,751,395 $7,153,627 0.23%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.03 44,400 Director 56,400 2022-08-11 Filing
$7.99 2,829 Director 12,000 2021-08-23 Filing
$8.05 3,000 Director 9,171 2021-08-19 Filing
$8.05 171 Director 6,171 2021-08-18 Filing
$8.10 6,000 Director 6,000 2021-08-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.03 4,511 Officer, Director 318,147 2022-04-27 Filing
$6.07 2,147 Officer, Director 322,658 2022-04-26 Filing
$6.03 2,036 Officer, Director 324,805 2022-04-25 Filing
$6.01 922 Officer, Director 326,841 2022-04-21 Filing
$6.02 367 Officer, Director 327,763 2022-04-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 10,683,789 $27,777,851 0.07%
2. 4,177,848 $10,862,405 0%
3. 3,670,516 $9,543,342 3.51%
4. 3,116,966 $8,104,112 0.01%
5. 2,551,794 $6,634,664 0.11%
News See All